These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17714521)
1. Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment. Tfelt-Hansen P; Edvinsson L Cephalalgia; 2007 Oct; 27(10):1091-3. PubMed ID: 17714521 [TBL] [Abstract][Full Text] [Related]
2. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics]. Kato K No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861 [No Abstract] [Full Text] [Related]
3. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Goadsby PJ; Yates R Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161 [TBL] [Abstract][Full Text] [Related]
4. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect. Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772 [TBL] [Abstract][Full Text] [Related]
5. Zelrix: a novel transdermal formulation of sumatriptan. Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727 [TBL] [Abstract][Full Text] [Related]
6. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Dodick DW; Martin V Cephalalgia; 2004 Jun; 24(6):417-24. PubMed ID: 15154851 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Chen LC; Ashcroft DM Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569 [TBL] [Abstract][Full Text] [Related]
8. Pathways to the best fit of triptans for migraine patients. Buzzi MG Cephalalgia; 2008 Sep; 28 Suppl 2():21-7. PubMed ID: 18715329 [TBL] [Abstract][Full Text] [Related]
10. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of triptans. Migraine patients have a choice]. MMW Fortschr Med; 2001 May; 143(22):51. PubMed ID: 11460406 [No Abstract] [Full Text] [Related]
15. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Peterlin BL; Rapoport AM Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):899-911. PubMed ID: 18028032 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the relationship between age and treatment response in migraine. Maas HJ; Danhof M; Della Pasqua OE Cephalalgia; 2009 Jul; 29(7):772-80. PubMed ID: 19281474 [TBL] [Abstract][Full Text] [Related]
17. [Triptans--pivotal event in migraine treatment]. Lusić I; Bilić I Acta Med Croatica; 2008 May; 62(2):173-8. PubMed ID: 18710081 [TBL] [Abstract][Full Text] [Related]